Advertisement
Canada markets open in 5 hours 11 minutes
  • S&P/TSX

    21,740.20
    -159.79 (-0.73%)
     
  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     
  • DOW

    37,735.11
    -248.13 (-0.65%)
     
  • CAD/USD

    0.7249
    -0.0004 (-0.06%)
     
  • CRUDE OIL

    85.37
    -0.04 (-0.05%)
     
  • Bitcoin CAD

    87,472.52
    -3,958.44 (-4.33%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,382.70
    -0.30 (-0.01%)
     
  • RUSSELL 2000

    1,975.71
    -27.47 (-1.37%)
     
  • 10-Yr Bond

    4.6280
    0.0000 (0.00%)
     
  • NASDAQ futures

    17,872.25
    -4.00 (-0.02%)
     
  • VOLATILITY

    19.18
    -0.05 (-0.26%)
     
  • FTSE

    7,858.43
    -107.10 (-1.34%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • CAD/EUR

    0.6824
    0.0000 (0.00%)
     

Nutrien Full Year 2023 Earnings: EPS Misses Expectations

Nutrien (TSE:NTR) Full Year 2023 Results

Key Financial Results

  • Revenue: US$28.1b (down 24% from FY 2022).

  • Net income: US$1.26b (down 84% from FY 2022).

  • Profit margin: 4.5% (down from 21% in FY 2022).

  • EPS: US$2.53 (down from US$14.23 in FY 2022).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Nutrien EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 27%.

Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 1.8% growth forecast for the Chemicals industry in Canada.

Performance of the Canadian Chemicals industry.

ADVERTISEMENT

The company's shares are up 7.5% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 4 warning signs with Nutrien, and understanding them should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.